TY  - JOUR
T1  - ANalysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation—reply
AU  - Wilson DM
Y1  - 2010/07/01
N1  - 10.1001/archpediatrics.2010.111
JO  - Archives of Pediatrics & Adolescent Medicine
SP  - 678
EP  - 679
VL  - 164
IS  - 7
N2  - 
The a priori primary end point of the study was change in adjusted BMI at the 52-week point. We fully expected that if there was an effect of metformin on BMI it would wane after drug treatment was stopped. We confirmed this expectation.

SN  - 1072-4710
M3  - doi: 10.1001/archpediatrics.2010.111
UR  - http://dx.doi.org/10.1001/archpediatrics.2010.111
ER  -